Table 2 Clinical characteristics and Chi-square analysis outputs of Rheumatic Heart Disease study subjects at Tikur Anbessa Specialized Hospital, 2021

Age at RHD diagnosis(yrs)

  < 20

264

68.8

18(6.8)

246(93.2)

 20 and above

120

31.2

19(15.8)

101(84.2)

RHD severity

 Mild

54

14.1

4(7.4)

50(92.6)

 Moderate

86

22.4

6(7)

80(93)

 Severe

244

63.5

27(11.1)

217(88.9)

Any comorbidity

 No

324

84.4

28(8.6)

296(91.4)

 Yes

60

15.6

9(15)

51(85)

Common Comorbidities or conditions

 Seizure disorders

7

1.8

1(14.3)

6(85.7)

 Hypertension

5

1.3

1(20)

4(80)

 HIV

4

1.0

0(0)

4(100)

 Chorea

4

1.0

1(25)

3(75)

 Pregnancy

2

0.5

0(0)

2(100)

 Others (anemia, myoma, pituitary adenoma, hypothyroidism etc)

24

6.3

4(16.7)

20(83.3)

NYHA class

 I

76

19.8

5(6.6)

71(93.4)

 II

164

42.7

15(9.1)

149(90.9)

 III

50

13

8(16)

42(84)

 IV

94

24.5

9(9.6)

85(90.4)

RHD related complication

 HF

48

12.5

4(8.3)

44(91.7)

 Stroke

16

4.2

0(0)

16(100)

 Rheumatic Recurrence

18

4.7

0(0)

18(100)

 Others (AF, AV block, LA thrombus…)

46

12

8(17.4)

38(82.6)

Number of drugs

 Single

9

2.3

1(11.1)

8(88.9)

 Multiple

375

97.7

36(9.6)

339(90.4)

Adherence to medications

 Good

297

77.3

23(7.7)

274(92.3)

 Poor or Satisfactory

87

22.7

14(16.1)

73(83.9)

Psychological support obtained from

 Family

349

90.9

27(7.7)

322(92.3)

 Friends

35

9.1

10(28.6)

25(71.4)

Hospital admission in the last 1 year

 Yes

100

26

14(14)

86(86)

 No

284

74

23(8.1)

261(91.9)

RHD intervention (Surgical or device)

 Yes

66

17.2

7(10.6)

59(89.4)

 No

318

82.8

30(9.4)

288(90.6)

Nutritional status

 Normal

337

87.8

31(9.2)

306(90.8)

 Mild wasting

29

7.6

4(13.8)

25(86.2)

 Moderate wasting

16

4.2

1(6.3)

15(93.8)

 Severe wasting

2

0.5

1(50)

1(50)